ID: ALA4565835

Max Phase: Preclinical

Molecular Formula: C45H75N13O13

Molecular Weight: 1006.17

Molecule Type: Unknown

Representations

Canonical SMILES:  CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](C)NC1=O

Standard InChI:  InChI=1S/C45H75N13O13/c1-21(2)18-28-39(66)51-25(7)43(70)58-17-11-14-32(58)44(71)57-16-10-13-31(57)41(68)52-27(12-9-15-48-45(46)47)37(64)56-34(26(8)59)42(69)55-30(20-33(60)61)40(67)54-29(19-22(3)4)38(65)50-23(5)35(62)49-24(6)36(63)53-28/h21-32,34,59H,9-20H2,1-8H3,(H,49,62)(H,50,65)(H,51,66)(H,52,68)(H,53,63)(H,54,67)(H,55,69)(H,56,64)(H,60,61)(H4,46,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31-,32+,34-/m0/s1

Standard InChI Key:  ITGNWGGHINGSKX-DGYQUFSYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1006.17

Molecular Weight (Monoisotopic): 1005.5607

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Reichart F, Maltsev OV, Kapp TG, Räder AFB, Weinmüller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester HJ, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H..  (2019)  Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.,  62  (4): [PMID:30657681] [10.1021/acs.jmedchem.8b01588]

Source

Source(1):

• Scientific Literature